Sodium ozagrel and atorvastatin for type 2 diabetes patients with lacunar cerebral infarction

doi:10.4239/wjd.v12.i12.2096

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 12

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5458)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

269

WORD

HTML

2332

Figures (1-2)

198

Tables (1-2)

386

Sum=3272

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

327

Download

735

Sum=1062

Publishing Process of This Article

Item

Count

Browse

372

Download

752

Sum=1124

Dec 15, 2021 (publication date) through Aug 25, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Diabetes. Dec 15, 2021; 12(12): 2096-2106
Published online Dec 15, 2021. doi: 10.4239/wjd.v12.i12.2096

Full Size Figure Download Figure

Figure 1 Graph of effective and ineffective treatment of cases in both groups.

Citation: Yu Y, Wang L, Zhu X, Liu YF, Ma HY. Sodium ozagrel and atorvastatin for type 2 diabetes patients with lacunar cerebral infarction. World J Diabetes 2021; 12(12): 2096-2106
URL: https://www.wjgnet.com/1948-9358/full/v12/i12/2096.htm
DOI: https://dx.doi.org/10.4239/wjd.v12.i12.2096